Home
Browse
Search
Statistics
About
Usage
PMID: 19124053
McDevitt CA, Collins R, Kerr ID, Callaghan R
Purification and structural analyses of ABCG2.
Adv Drug Deliv Rev. 2009 Jan 31;61(1):57-65. Epub 2008 Dec 13., 2009-01-31
[PubMed]
Sentences
No.
Mutations
Sentence
Comment
717
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:717:71
status:
NEW
view ABCG2 p.Arg482Gly details
Perhaps the most significant variation in pharmacology arises with the
R482G
mutation, which dramatically alters the substrate specificity of ABCG2 and may provide clues into the site of drug interaction on theprotein [18,19].
Login to comment
722
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:722:50
status:
NEW
view ABCG2 p.Arg482Gly details
The substrate specificities for the wild-type and
R482G
isoforms have been reasonably well characterised with respect to drug transport and the ability to confer resistance [3,19].
Login to comment
725
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:725:395
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:725:753
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:135
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:224
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:438
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:700
status:
NEW
view ABCG2 p.Arg482Gly details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:725:805
status:
NEW
view ABCG2 p.Arg482Gly details
Table 1 Investigations reporting ATPase activity of various ABCG2 isoforms Isoform ATPase activity Drug effect Reference Vmax Km (ATP)
R482G
(B) 45 nmol min-1 mg-1 - Prazosin IC50 =5 μM [61] Vi inhibits at 50 μM
R482G
(B) 15 nmol min-1 mg-1 - [21] (S) 32 nmol min-1 mg-1 WT (B) 27 nmol min-1 mg-1 (S) 29 nmol min-1 mg-1 WT (pure) (B) 357 nmol min-1 mg-1 2 mM Vi inhibits 60-80% [20]
R482T
(pure) (B) 1111 nmol min-1 mg-1 1 mM
R482G
(B) 10 nmol min-1 mg-1 Stimulated activity at 100 μM prazosin [57] (S) 30 nmol min-1 mg-1 WT (B) 40 nmol min-1 mg-1 - Activities are Vi sensitive [19] (S) 41 nmol min-1 mg-1 Activities reported at a fixed [ATP] and not full Michaelis-Menten analysis
R482G
(B) 65 nmol min-1 mg-1 (S) 140 nmol min-1 mg-1
R482T
(B) 42 nmol min-1 mg-1 (S) 81 nmol min-1 mg-1
R482G
(B) 70 nmol min-1 mg-1 - Prazosin IC50 =1 μM and fold-stimulation was 2X [30] (S) 150 nmol min-1 mg-1 The Michaelis-Menten characteristics for ATPase activity by a number of isoforms of ABCG2 are tabulated from a number of source references.
Login to comment
732
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:732:14
status:
NEW
view ABCG2 p.Arg482Gly details
Wild-type and
R482G
ABCG2 isoforms are capable of ATP hydrolysis in the absence of any substrate although the Vmax for hydrolysis of 30-50 nmol Pi min-1 mg-1 is considerably lower than that shown for ABCB1.
Login to comment
733
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:733:93
status:
NEW
view ABCG2 p.Arg482Gly details
The most pronounced stimulation of ATP hydrolysis by substrate has been demonstrated for the
R482G
mutant in the presence of micromolar concentrations of prazosin.
Login to comment
734
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:734:11
status:
NEW
view ABCG2 p.Arg482Gly details
Unlike the
R482G
isoform, the wild-type protein was insensitive to stimulation by many drugs and increased nucleotide trapping in the presence of substrates could not be demonstrated [19].
Login to comment
745
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:745:105
status:
NEW
view ABCG2 p.Arg482Gly details
For example, mitoxantrone was more efficient at displacing [125 I]-IAA-Rh123 binding to wild-type versus
R482G
, but the latter isoform was able to confer greater levels of resistance to the anticancer drug.
Login to comment
747
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:747:48
status:
NEW
view ABCG2 p.Arg482Gly details
An equilibrium and kinetic binding study on the
R482G
isoform of ABCG2 revealed the presence of multiple drug interaction sites on the protein [23].
Login to comment
760
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:760:81
status:
NEW
view ABCG2 p.Arg482Thr details
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:760:74
status:
NEW
view ABCG2 p.Arg482Gly details
The first studies of ABCG2, and its pharmacologically differing isoforms (
R482G
,
R482T
), were conducted in drug selected mammalian cell lines due to the relative simplicity of inducing its expression by drug treatment [26,27].
Login to comment
768
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:768:101
status:
NEW
view ABCG2 p.Arg482Gly details
Janvilisri and co-workers utilised Lactococcus (L.) lactis as an expression system for wild-type and
R482G
ABCG2 [28,33] employing the nisin A-induced expression system that had previously been used for the expression of the prokaryotic ABC transporter LmrA [34].
Login to comment
795
ABCG2 p.Arg482Thr
X
ABCG2 p.Arg482Thr 19124053:795:126
status:
NEW
view ABCG2 p.Arg482Thr details
This study reported a percentage yield of ABCG2 of ~1.3% (membrane protein) and an approximately two fold lower yield for the
R482T
isoform.
Login to comment
800
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:800:89
status:
NEW
view ABCG2 p.Arg482Gly details
Despite this lower affinity, a similar yield of ~1% was observed after IMAC for both the
R482G
isoform and the wild type (unpublished data).
Login to comment
864
ABCG2 p.Arg482Gly
X
ABCG2 p.Arg482Gly 19124053:864:65
status:
NEW
view ABCG2 p.Arg482Gly details
A large oligomeric complex (molecular weight of ~600 kDa) of the
R482G
isoform was identified by Blue-native PAGE and electron microscopy [37].
Login to comment